Analysts upgrade Tenet shares — 4 quick facts


 Vet analysts upgraded Tenet shares from a “hold” rating to a “buy” rating, according to MidSouth News & Analysis.

Advertisement

Here are four quick facts:

1. Vet has a $34.02 price target on Tenet stock.

2. On Nov. 13, Glenview Capital Management major shareholder bought 900,000 Tenet shares for a total transaction of nearly $29 million.

3. Tenet has a 50-day moving average of $33.74 and a 200-day moving average of $46.88.

4. The market cap is $3.21 billion.

Click here to read more about Tenet’s Q3 financial report. 

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.